Decreased Infarct Volume and Intracranial Hemorrhage Associated with Intra-Arterial Nonionic Iso-Osmolar Contrast Material in an MCA Occlusion/Reperfusion Model

REFERENCES

1. 1.↵
   2. Hom J,
   3. Dankbaar JW,
   4. Soares BP, et al

   . Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol 2011;32:41–48

   Abstract/FREE Full Text
2. 2.↵
   2. Aviv RI,
   3. d'Esterre CD,
   4. Murphy BD, et al

   . Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology 2009;250:867–77

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Lin K,
   3. Kazmi KS,
   4. Law M, et al

   . Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol 2007;28:1292–98

   Abstract/FREE Full Text
4. 4.↵
   2. Lummel N,
   3. Schulte-Altedorneburg G,
   4. Bernau C, et al

   . hyperattenuated intracerebral lesions after mechanical recanalization in acute stroke. AJNR Am J Neuroradiol 2014;35:345–51

   Abstract/FREE Full Text
5. 5.↵
   2. Kurosawa Y,
   3. Lu A,
   4. Khatri P, et al

   . Intra-arterial iodinated radiographic contrast material injection administration in a rat middle cerebral artery occlusion and reperfusion model: possible effects on intracerebral hemorrhage. Stroke 2010;41:1013–17

   Abstract/FREE Full Text
6. 6.↵
   2. Koizumi A,
   3. Yoshida Y,
   4. Nakazawa T, et al

   . Experimental studies of ischemic brain edema: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986;8:1–8

   CrossRef
7. 7.↵
   2. Longa EZ,
   3. Weinstein PR,
   4. Carlson S, et al

   . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84–91

   Abstract/FREE Full Text
8. 8.↵
   2. Nestler U,
   3. Seifner S,
   4. Greschus S, et al

   . Doppler ultrasonographic measurement of blood flow velocities in major cerebral arteries of the rat using triplex mode. Neurol Res 2006;28:877–80

   CrossRefPubMed
9. 9.↵
   2. Zhang RL,
   3. Chopp M,
   4. Zhang ZG, et al

   . A rat model of focal embolic cerebral ischemia. Brain Res 1997;766:83–92

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Lapchak PA,
    3. Chapman DF,
    4. Zivin JA

    . Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 2000;31:3034–40

    Abstract/FREE Full Text
11. 11.↵
    2. Lapchak PA,
    3. Araujo DM,
    4. Song D, et al

    . The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke. Stroke 2002;33:147–52

    Abstract/FREE Full Text
12. 12.↵
    2. Lu A,
    3. Clark JF,
    4. Broderick JP, et al

    . Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol 2009;216:407–12

    CrossRefPubMed
13. 13.↵
    1. Edvinsson L,
    2. MacKenzie ET,
    3. McCulloch J

    2. Edvinsson L,
    3. MacKenzie ET,
    4. McCulloch J

    . General and comparative anatomy of the cerebral circulation. In: Edvinsson L, MacKenzie ET, McCulloch J. Cerebral Blood Flow and Metabolism. New York: Raven Press; 1993:3–39
14. 14.↵
    2. Aulie Michelet A

    . Effects of intravascular contrast media on blood-brain barrier: comparison between iothalamate, iohexol, iopentol and iodixanol. Acta Radiol 1987;28:329–33

    Abstract/FREE Full Text
15. 15.↵
    2. Sage MR,
    3. Wilson AJ,
    4. Scroop R

    . Contrast media and the brain: the basis of CT and MR imaging enhancement. Neuroimaging Clin N Am 1998;8:695–707

    PubMed
16. 16.↵
    2. Sage MR,
    3. Wilcox J,
    4. Evill CA, et al

    . Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate. AJNR Am J Neuroradiol 1983;4:893–95

    Abstract/FREE Full Text
17. 17.↵
    2. Hayakawa K,
    3. Morris TM,
    4. Katzberg RW

    . Opening of the blood-brain barrier by intravenous contrast media in euvolemic and dehydrated rabbits. Acta Radiol 1989;30:439–44

    Abstract/FREE Full Text
18. 18.↵
    2. Doerfler A,
    3. Engelhorn T,
    4. von Kummer R, et al

    . Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats. Radiology 1998;206:211–17

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Pannu N,
    3. Wiebe N,
    4. Tonelli M

    . Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765–79

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Fountaine H,
    3. Harnish P,
    4. Andrew E, et al

    . Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. Acad Radiol 1996(3 suppl 3):S475–84
21. 21.↵
    2. Finley Caulfield A,
    3. Wijman CA

    . Management of acute ischemic stroke. Neurol Clin 2008;26:345–71, vii

    CrossRefPubMed
22. 22.↵
    2. Diringer MN,
    3. Zazulia AR

    . Osmotic therapy: fact and fiction. Neurocrit Care 2004;1:219–33

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Qureshi AI,
    3. Wilson DA,
    4. Traystman RJ

    . Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery 1999;44:1055–63, discussion 1063–64

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Franke RP,
    3. Fuhrmann R,
    4. Hiebl B, et al

    . Influence of various radiographic contrast media on the buckling of endothelial cells. Microvasc Res 2008;76:110–13

    CrossRefPubMed
25. 25.↵
    2. Wilcox J,
    3. Wilson AJ,
    4. Evill CA, et al

    . A comparison of blood-brain barrier disruption by intracarotid iohexol and iodixanol in the rabbit. AJNR Am J Neuroradiol 1987;8:769–72

    Abstract/FREE Full Text
26. 26.↵
    2. Macdougall NJ,
    3. McVerry F,
    4. Baird S, et al

    . Iodinated contrast media and cerebral hemorrhage after intravenous thrombolysis. Stroke 2011;42:2170–74

    Abstract/FREE Full Text
27. 27.↵
    2. Khatri P,
    3. Broderick JP,
    4. Khoury JC, et al

    . Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk. Stroke 2008;39:3283–87

    Abstract/FREE Full Text
28. 28.↵
    2. Leong S,
    3. Fanning NF

    . Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling: a case report and review of the literature. Interv Neuroradiol 2012;18:33–41

    Abstract/FREE Full Text
29. 29.↵
    2. Hayman LA,
    3. Evans RA,
    4. Bastion FO, et al

    . Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. AJR Am J Roentgenol 1981;136:1151–59

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Heinrich MC,
    3. Kuhlmann MK,
    4. Grgic A, et al

    . Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 2005;235:843–49

    CrossRefPubMedWeb of Science
31. 31.↵
    2. McClennan BL,
    3. Stolberg HO

    . Intravascular contrast media: ionic versus nonionic—current status. Radiol Clin North Am 1991;29:437–54

    PubMedWeb of Science
32. 32.↵
    2. Dooley M,
    3. Jarvis B

    . Iomeprol: a review of its use as a contrast medium. Drugs 2000;59:1169–86

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Sood R,
    3. Taheri S,
    4. Estrada EY, et al

    . Quantitative evaluation of the effect of propylene glycol on BBB permeability. J Magn Reson Imaging 2007;25:39–47

    CrossRefPubMed
34. 34.↵
    2. Jacobsen PB,
    3. Larsen A,
    4. Konarboland R, et al

    . Biotransformation of nonionic x-ray contrast agents in vivo and in vitro. Drug Metab Dispos 1999;27:1205–13

    Abstract/FREE Full Text
35. 35.↵
    2. Spencer CM,
    3. Goa KL

    . Iodixanol: a review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs 1996;52:899–927

    CrossRefPubMed
36. 36.↵
    2. Aspelin P,
    3. Stacul F,
    4. Thomsen HS, et al

    . Effects of iodinated contrast media on blood and endothelium. Eur Radiol 2006;16:1041–49

    CrossRefPubMed
37. 37.↵
    2. Georgakis A,
    3. Ener RA,
    4. Jin J, et al

    . Risk of thrombogenicity among nonionic radiocontrast agents. J Invasive Cardiol 2008;20:349–53

    PubMed
38. 38.↵
    2. Kim SJ,
    3. Salem MR,
    4. Joseph NJ, et al

    . Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg 1990;71:73–76

    PubMedWeb of Science
39. 39.↵
    2. Wilcox J,
    3. Sage MR

    . Is viscosity important in the production of blood-brain barrier disruption by intracarotid contrast media? Neuroradiology 1984;26:511–13

    CrossRefPubMed
40. 40.↵
    2. Dirnagl U,
    3. Lindauer U,
    4. Them A, et al

    . Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab 1995;15:929–40

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Kumura E,
    3. Yoshimine T,
    4. Iwatsuki KI, et al

    . Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats. Am J Physiol 1996;270:C748–52
42. 42.↵
    2. Rosell A,
    3. Foerch C,
    4. Murata Y, et al

    . Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir Suppl 2008;105:173–78

    CrossRefPubMed
43. 43.↵
    2. Lu A,
    3. Clark JF,
    4. Broderick JP, et al

    . Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol 2008;210:549–59

    CrossRefPubMed
44. 44.↵
    2. Zador Z,
    3. Stiver S,
    4. Wang V, et al

    . Role of aquaporin-4 in cerebral edema and stroke. Handb Exp Pharmacol 2009:159–70
45. 45.↵
    2. Simard JM,
    3. Kent TA,
    4. Chen M, et al

    . Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 2007;6:258–68

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Kim EY,
    3. Na DG,
    4. Kim SS, et al

    . Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am J Neuroradiol 2005;26:1050–55

    Abstract/FREE Full Text
47. 47.↵
    2. Tong DC,
    3. Adami A,
    4. Moseley ME, et al

    . Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol 2001;58:587–93

    CrossRefPubMed
48. 48.↵
    2. Hoehn-Berlage M,
    3. Norris DG,
    4. Kohno K, et al

    . Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995;15:1002–11

    CrossRefPubMedWeb of Science
49. 49.↵
    2. Knight RA,
    3. Barker PB,
    4. Fagan SC, et al

    . Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 1998;29:144–51

    Abstract/FREE Full Text
50. 50.↵
    2. Reglodi D,
    3. Somogyvari-Vigh A,
    4. Maderdrut JL, et al

    . Postischemic spontaneous hyperthermia and its effects in middle cerebral artery occlusion in the rat. Exp Neurol 2000;163:399–407

    CrossRefPubMedWeb of Science